Memory beliefs and function in fibromyalgia patients.

Institute for Social Research, University of Michigan, 426 Thompson Street, Ann Arbor, MI 48106, United States.
Journal of Psychosomatic Research (Impact Factor: 2.84). 04/2005; 58(3):263-9. DOI: 10.1016/j.jpsychores.2004.09.004
Source: PubMed

ABSTRACT The aim of this study was to investigate memory beliefs and their relationship to actual memory function in fibromyalgia (FM) patients.
Twenty-three FM patients, 23 age- and education-matched controls, and 22 older controls completed the Metamemory in Adulthood (MIA) questionnaire, which assessed beliefs about seven aspects of memory function. Group differences on the seven scales were assessed, and scores on the capacity scale were correlated with objective memory performance.
FM patients reported lower memory capacity and more memory deterioration than did either control group. Patients reported lower control or self-efficacy over memory, higher achievement motivation, higher strategy use, and higher anxiety about memory than age-matched controls did. Among the patients, perceived capacity, achievement motivation, and self-efficacy were significantly correlated with objective memory performance on a recall task.
FM patients' complaints about memory function have some accuracy.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this research is to test the psychometric properties of the Questionnaire d’auto-efficacité mnésique (QAEM), the French version of the Memory Self-Efficacy Questionnaire (MSEQ). Reliability and validity of the MSEQ. Dev. Psychol. 25 (1989) 701–713, a scale based on Bandura's self-efficacy theory. After reviewing previous research into memory self-efficacy (MSE), we present a validation study for the QAEM, conducted on a sample of 288 older adults. The QAEM was found to show comparable reliability, sensitivity and construct validity to the MSEQ. The QAEM scores correlated with other metamemory variables and, weakly, with episodic memory performances.
    Revue Européenne de Psychologie Appliquée 09/2008; 58(3):165-176. DOI:10.1016/j.erap.2007.09.001 · 0.52 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: En: Psicothema Oviedo 2008, v. 20, n. 3 ; p. 427-431 Estudios previos han mostrado la presencia de alteraciones cognitivas en los pacientes con síndrome de fibromialgia (SFM), sin embargo, no han determinado la posible influencia de las distintas variables clínicas en estas alteraciones. El primer objetivo de nuestro estudio es determinar las diferencias en la función cognitiva entre 81 pacientes con SFM y 35 controles sanos mediante una batería de tests neuropsicológicos. El segundo objetivo es determinar la influencia de la ansiedad y el dolor en la función cognitiva en pacientes con SFM. Los resultados de nuestro estudio muestran que las pacientes con SFM desarrollan un rendimiento cognitivo significativamente inferior a los controles sanos en todos los parámetros valorados. El rendimiento neuropsicológico en pacientes con SFM está asociado al dolor, siendo esta relación independiente del nivel de ansiedad. La relación entre el rendimiento cognitivo y la ansiedad también es significativa. Por esta razón, concluimos que el rendimiento cognitivo está principalmente afectado por el dolor, pero además, el nivel de ansiedad explica parte de la variabilidad en los tests neuropsicológicos que no es explicada por el dolor
    Psicothema 01/2008; 20(3). · 0.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We sought to determine the predictors of incident chronic widespread pain (CWP), specifically, the effect of preexisting symptoms, stress, and psychosocial factors in the subsequent development of CWP among veterans from the first Gulf War (GW). We conducted a structured telephone survey (baseline) of military personnel originally from Iowa who were either eligible for or deployed to Operation Desert Shield/Desert Storm, approximately 5 years postconflict. We conducted a follow-up, clinical, in-person study of those who met a priori-defined outcomes of symptoms of cognitive dysfunction, depression, or CWP, and also a sample of those who did not meet any of the outcomes of interest. A total of 370 of 602 evaluated GW veterans were free of CWP 5 years postconflict. At follow-up, 69 (19%) of these had developed CWP. A positive family history of medically unexplained persistent symptoms [odds ratio (OR)=4.8 (2.3, 13.2)] was strongly associated with CWP. At baseline, individuals who reported preexisting symptoms of bronchitis [OR=4.9 (1.9, 12.3)] and cognitive dysfunction [OR=2.1 (1.1, 4.2)] were more likely to develop CWP. Alcohol use [OR=0.2 (0.1, 0.7)] was protective against CWP. Rather than combat-related exposure per se, the perception of stress at the time of the GW [OR=1.6 (1.1, 2.3)] correlated with CWP. Among the GW veterans evaluated longitudinally in this study, family history, predeployment symptoms, and the level of perceived stress during the GW were associated with subsequent development of CWP.
    Clinical Journal of Pain 01/2006; 22(6):554-63. DOI:10.1097/01.ajp.0000208907.42506.21 · 2.70 Impact Factor